Literature DB >> 21734790

NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease.

Dylan M Glubb1, Richard B Gearry, Murray L Barclay, Rebecca L Roberts, John Pearson, Jacqui I Keenan, Judy McKenzie, Robert W Bentley.   

Abstract

AIM: To assess whether polymorphisms in NOD2 and ATG16L1 affect cytokine responses and mycobacterium avium subspecies paratuberculosis (MAP) survival in monocytes from Crohn's disease (CD) patients.
METHODS: Monocytes were isolated from peripheral blood of CD patients of known genotype for common single nucleotide polymorphisms of NOD2 and ATG16L1. Monocytes were challenged with MAP and bacterial persistence assessed at subsequent time-points. Cytokine responses were assayed using a Milliplex multi-analyte profiling assay for 13 cytokines.
RESULTS: Monocytes heterozygous for a NOD2 polymorphism (R702W, P268S, or 1007fs) were more permissive for growth of MAP (P = 0.045) than those without. There was no effect of NOD2 genotype on subsequent cytokine expression. The T300A polymorphism of ATG16L1 did not affect growth of MAP in our model (P = 0.175), but did increase expression of cytokines interleukin (IL)-10 (P = 0.047) and IL-6 (P = 0.019).
CONCLUSION: CD-associated polymorphisms affected the elimination of MAP from ex vivo monocytes (NOD2), or expression of certain cytokines (ATG16L1), implying independent but contributory roles in the pathogenesis of CD.

Entities:  

Keywords:  Autophagy; CARD15; Cytokine; Inflammatory bowel disease; Mycobacterium avium subspecies paratuberculosis

Mesh:

Substances:

Year:  2011        PMID: 21734790      PMCID: PMC3120942          DOI: 10.3748/wjg.v17.i23.2829

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  46 in total

Review 1.  The genetics of inflammatory bowel disease.

Authors:  Denise K Bonen; Judy H Cho
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

3.  Images of interest. Gastrointestinal: Mycobacterium avium paratuberculosis and Crohn's disease.

Authors:  R B Gearry; J M Aitken; R L Roberts; S Ismail; J Keenan; M L Barclay
Journal:  J Gastroenterol Hepatol       Date:  2005-12       Impact factor: 4.029

4.  High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study.

Authors:  Richard B Gearry; Ann Richardson; Christopher M A Frampton; Judith A Collett; Michael J Burt; Bruce A Chapman; Murray L Barclay
Journal:  Inflamm Bowel Dis       Date:  2006-10       Impact factor: 5.325

5.  Human IRGM induces autophagy to eliminate intracellular mycobacteria.

Authors:  Sudha B Singh; Alexander S Davis; Gregory A Taylor; Vojo Deretic
Journal:  Science       Date:  2006-08-03       Impact factor: 47.728

6.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis.

Authors:  John D Rioux; Ramnik J Xavier; Kent D Taylor; Mark S Silverberg; Philippe Goyette; Alan Huett; Todd Green; Petric Kuballa; M Michael Barmada; Lisa Wu Datta; Yin Yao Shugart; Anne M Griffiths; Stephan R Targan; Andrew F Ippoliti; Edmond-Jean Bernard; Ling Mei; Dan L Nicolae; Miguel Regueiro; L Philip Schumm; A Hillary Steinhart; Jerome I Rotter; Richard H Duerr; Judy H Cho; Mark J Daly; Steven R Brant
Journal:  Nat Genet       Date:  2007-04-15       Impact factor: 38.330

7.  Clinical patterns of familial inflammatory bowel disease.

Authors:  J Satsangi; C Grootscholten; H Holt; D P Jewell
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

8.  Rapid detection of common CARD15 variants in patients with inflammatory bowel disease.

Authors:  Rebecca L Roberts; Richard B Gearry; Murray L Barclay; Martin A Kennedy
Journal:  Mol Diagn       Date:  2004

9.  Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease.

Authors:  F Kallinowski; A Wassmer; M A Hofmann; D Harmsen; J Heesemann; H Karch; C Herfarth; H J Buhr
Journal:  Hepatogastroenterology       Date:  1998 Sep-Oct

10.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.

Authors:  Jochen Hampe; Andre Franke; Philip Rosenstiel; Andreas Till; Markus Teuber; Klaus Huse; Mario Albrecht; Gabriele Mayr; Francisco M De La Vega; Jason Briggs; Simone Günther; Natalie J Prescott; Clive M Onnie; Robert Häsler; Bence Sipos; Ulrich R Fölsch; Thomas Lengauer; Matthias Platzer; Christopher G Mathew; Michael Krawczak; Stefan Schreiber
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

View more
  10 in total

Review 1.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

2.  Uptake and persistence of Mycobacterium avium subsp. paratuberculosis in human monocytes.

Authors:  Dayle A Keown; David A Collings; Jacqueline I Keenan
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

3.  Role of autophagy genetic variants for the risk of Candida infections.

Authors:  Diana C Rosentul; Theo S Plantinga; Marius Farcas; Marije Oosting; Omar J M Hamza; William K Scott; Barbara D Alexander; John C Yang; Gregory M Laird; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart-Jan Kullberg; Andre J A M van der Ven; Melissa D Johnson; Mihai G Netea
Journal:  Med Mycol       Date:  2014-04-08       Impact factor: 4.076

4.  Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B).

Authors:  James P Dalton; Alan Desmond; Fergus Shanahan; Colin Hill
Journal:  Med Microbiol Immunol       Date:  2014-02-13       Impact factor: 3.402

5.  ATG16L1 and NOD2 polymorphisms enhance phagocytosis in monocytes of Crohn's disease patients.

Authors:  Simone C S Wolfkamp; Caroline Verseyden; Esther W M Vogels; Sander Meisner; Kirsten Boonstra; Charlotte P Peters; Pieter C F Stokkers; Anje A te Velde
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

6.  The role of autophagy in Crohn's disease.

Authors:  Paul Henderson; Craig Stevens
Journal:  Cells       Date:  2012-08-03       Impact factor: 6.600

7.  Autophagy mediates ER stress and inflammation in Helicobacter pylori-related gastric cancer.

Authors:  M C Mommersteeg; I Simovic; B Yu; S A V van Nieuwenburg; I M J Bruno; M Doukas; E J Kuipers; M C W Spaander; M P Peppelenbosch; N Castaño-Rodríguez; G M Fuhler
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 8.  Genetic and functional profiling of Crohn's disease: autophagy mechanism and susceptibility to infectious diseases.

Authors:  Annalisa Marcuzzi; Anna Monica Bianco; Martina Girardelli; Alberto Tommasini; Stefano Martelossi; Lorenzo Monasta; Sergio Crovella
Journal:  Biomed Res Int       Date:  2013-05-08       Impact factor: 3.411

Review 9.  The Interplay between NLRs and Autophagy in Immunity and Inflammation.

Authors:  Leticia A M Carneiro; Leonardo H Travassos
Journal:  Front Immunol       Date:  2013-11-11       Impact factor: 7.561

Review 10.  Interactions between Autophagy and Inhibitory Cytokines.

Authors:  Tian-Tian Wu; Wei-Min Li; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2016-06-07       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.